ORIGINAL RESEARCH article

Front. Oncol., 24 September 2020

Sec. Cancer Molecular Targets and Therapeutics

Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.533176

RETRACTED: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation

Updated

Hongbo Qu
Hongbo Qu1*Fang ZhuFang Zhu2Huaying DongHuaying Dong3Xiongqiang HuXiongqiang Hu1Mingli HanMingli Han4
  • 1Department of Breast and Thyroid Surgery, The First People's Hospital of Chenzhou, Chenzhou, China
  • 2Department of Breast Health Center, The First People's Hospital of Chenzhou (South Hospital), Chenzhou, China
  • 3Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou, China
  • 4Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Citation: Qu H, Zhu F, Dong H, Hu X and Han M (2020) Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation. Front. Oncol. 10:533176. doi: 10.3389/fonc.2020.533176

Received: 30 March 2020; Accepted: 18 August 2020;
Published: 24 September 2020; Retracted: 26 February 2025.

Edited by:

Marie R. Webster, Lankenau Institute for Medical Research, United States

Reviewed by:

Yogesh Chawla, Mayo Clinic, United States
Hailin Tang, Sun Yat-sen University Cancer Center (SYSUCC), China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.